SCHEMBL6172653

SCHEMBL6172653

CNC(=O)C(c1ccnc(-c2ccc(Cl)cc2)c1)N1CC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 18/20 0.38
XIAP P98170 1/20 0.33
BIRC2 Q13490 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173179 0.86 IGF1R (0.49) IGF1RXIAPBIRC2
SCHEMBL6171982 0.77 IGF1R (0.41) IGF1R
SCHEMBL6174468 0.74 IGF1R (0.40) IGF1R
SCHEMBL2941287 0.74 IGF1R (0.49) IGF1R
SCHEMBL6173451 0.72 IGF1R (0.41) IGF1RXIAPBIRC2
SCHEMBL6175552 0.71 IGF1R (0.38) IGF1R
SCHEMBL6173810 0.68 MAPT (0.35)
SCHEMBL6173911 0.66 IGF1R (0.42) IGF1R
SCHEMBL2935234 0.66 IGF1R (0.48) IGF1R
SCHEMBL2938509 0.66 SMO (0.52) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed